Moving beyond generative AI hype and into widespread adoption

Generative AI (GenAI) has rapidly pushed its way to the forefront of tech innovation. Its rise has fueled massive hype, speculation and excitement. Still, some observers remain cautious, emphasizing the challenges that may limit its real-world impact. In Pharmaphorum, Rohit Gupta discusses how the pharmaceutical industry can leverage the best of GenAI, speeding adoption and generating a sharp rise in impact.